Trademark Attorney / Law Firm
NORMAN P. ROUSSEAU – Trademark Portfolio
NORMAN P. ROUSSEAU specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 26 of 34 total filings concentrated in this category. The practice also covers Class 1 (Chemicals) along with 4 other Nice Classification classes. Filing activity spans from 1984 to 1989. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
NORMAN P. ROUSSEAU's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademark applications has NORMAN P. ROUSSEAU filed?
NORMAN P. ROUSSEAU has filed 34 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does NORMAN P. ROUSSEAU specialize in?
NORMAN P. ROUSSEAU has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has NORMAN P. ROUSSEAU been filing trademarks?
NORMAN P. ROUSSEAU's trademark filing history with the USPTO spans from 1984 to 1989, covering 5 years of trademark practice. During this period, NORMAN P. ROUSSEAU has handled 34 trademark applications.
What is NORMAN P. ROUSSEAU's trademark registration success rate?
NORMAN P. ROUSSEAU has a 0% trademark registration rate, with 0 out of 34 resolved applications resulting in successful registration. Currently, 0 applications are pending review.